
Chemomab Therapeutics
Clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.
Market cap
$22.4m
Enterprise value
$12m
Share price
$1.16 CMMB
Authorizing premium user...
Clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.